Surge in Federal Approvals Buoys Drug Makers

Published January 12, 2013

Surge in federal approvals buoys drug makers

Filed under: drug treatment programs in san francisco

SAN FRANCISCO — Something odd is going on in the pharmaceutical world: Though the industry is coping with a sluggish economy and bracing for federal cuts in medical research funding, the mood among the 8,000 executives at the industry's premier …
Read more on Bostonglobe

Diabetes drug raises FDA's concerns

Filed under: drug treatment programs in san francisco

The drugmaker has proposed marketing canagliflozin under the name Invokana for adults with Type 2 diabetes. It worked as well against diabetes in clinical trials as Januvia, Merck & Co.'s second-best-selling drug, and a generic treatment called …
Read more on San Francisco Chronicle

Amgen's Cash Allocation Process [ANALYSIS]

Filed under: drug treatment programs in san francisco

On July 5, 2012, Amgen announced the completion of the acquisition of KAI Pharmaceuticals, a privately held company based in South San Francisco acquiring candidate KAI-4169, a novel agent for the treatment of secondary hyperparathyroidism in patients …
Read more on ValueWalk

San Francisco Drug Treatment – www.altamirarecovery.com